Birdwatch Note Rating
2024-11-29 02:44:39 UTC - HELPFUL
Rated by Participant: 5D0CB2D29C3FDF93AC1B4AE5CC64805F07CA876456CB9E9A642D55244BEFB136
Participant Details
Original Note:
The new rule proposal does not mandate Ozempic as an obesity treatment. The proposed rule changes a decades-old Medicare rule that prohibits the program from covering weight loss drugs. This makes Ozempic and other semaglutides available to those covered by Medicare. https://apnews.com/article/ozempic-biden-rfk-jr-trump-antiobesity-drugs-caaa2f888435af1d32bedb83e9ddbc0a
All Note Details